Methylmalonic Acidemia (MMA) is a rare inherited metabolic disorder in which the body cannot properly break down certain proteins and fats. This leads to the accumulation of methylmalonic acid, a toxic substance that can damage vital organs, especially the kidneys, brain, and liver.
MMA affects approximately 1 in 50,000–100,000 newborns.
MMA is caused by a problem with:
Normally:
In MMA:
1. Enzyme Defect Types
2. Vitamin B12–Related Types
3. B12-Responsive vs. Unresponsive MMA
Early symptoms often appear in the first days or weeks of life:
Symptoms in Childhood:
Even with treatment, some children may develop:
Early diagnosis and strict management greatly reduce the severity of complications.
1. Newborn Screening:
Most MMA cases are detected through routine heel-prick screening by identifying high C3 (propionylcarnitine).
2. Confirmatory Testing:
MMA requires lifelong, daily treatment and emergency planning.
1. Special Diet (Cornerstone of Treatment):
Diet is supervised by a metabolic dietitian.
2. Vitamin B12 Therapy:
Applies only to B12-responsive types (cblA, some cblB, some cblC):
3. Carnitine Supplementation:
4. Medications to Reduce Toxin Production:
5. Managing a Metabolic Crisis:
A crisis may occur during:
Emergency care includes:
Families should always carry a written emergency protocol.
Liver Transplant:
Helps in severe or unstable MMA by:
Important: Liver transplant does not cure MMA.
Kidney disease and neurologic issues may still progress.
Combined Liver–Kidney Transplant:
Considered in children with advanced kidney disease.
Children require follow-up every 3–6 months, including:
Most children with MMA can:
Families benefit from: